tiprankstipranks
Nkarta initiates trial of NKX019 in lupus nephritis
PremiumThe FlyNkarta initiates trial of NKX019 in lupus nephritis
25d ago
Nkarta Initiates Clinical Trial of NKX019 in Lupus Nephritis with First Patient in Screening and Announces Pipeline Expansion to Additional Autoimmune Indications
PremiumPress Releases
Nkarta Initiates Clinical Trial of NKX019 in Lupus Nephritis with First Patient in Screening and Announces Pipeline Expansion to Additional Autoimmune Indications
25d ago
Nkarta’s Annual Meeting Results in Key Corporate Decisions
PremiumCompany Announcements
Nkarta’s Annual Meeting Results in Key Corporate Decisions
1M ago
Nkarta to Participate in Upcoming Investor Conferences
PremiumPress ReleasesNkarta to Participate in Upcoming Investor Conferences
4M ago
Nkarta director buys $20M in common stock
PremiumThe Fly
Nkarta director buys $20M in common stock
4M ago
Promising Biopharma Nkarta (NASDAQ:NKTX) Not for the Faint-Hearted
PremiumMarket News
Promising Biopharma Nkarta (NASDAQ:NKTX) Not for the Faint-Hearted
4M ago
Nkarta trading resumes
PremiumThe FlyNkarta trading resumes
4M ago
Nkarta trading halted, volatility trading pause
PremiumThe Fly
Nkarta trading halted, volatility trading pause
4M ago
Nkarta price target lowered to $25 from $31 at Mizuho
PremiumThe Fly
Nkarta price target lowered to $25 from $31 at Mizuho
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100